Published in Pediatr Transplant on February 01, 2005
Simultaneous detection and high-throughput identification of a panel of RNA viruses causing respiratory tract infections. J Clin Microbiol (2007) 2.14
De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection. J Immunol (2008) 1.95
Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24
Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant (2008) 1.15
Longitudinal analysis of the lung microbiome in lung transplantation. FEMS Microbiol Lett (2012) 1.10
Allopeptides and the alloimmune response. Cell Immunol (2007) 0.90
A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy. Transplantation (2011) 0.90
Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells. PLoS One (2010) 0.90
Novel insights into lung transplant rejection by microarray analysis. Proc Am Thorac Soc (2007) 0.89
Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies. Immunology (2010) 0.86
Clinical outcomes of lung transplant recipients with telomerase mutations. J Heart Lung Transplant (2015) 0.84
Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation. Transpl Immunol (2007) 0.82
Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease. Exp Lung Res (2011) 0.81
Hypothermic preservation of lung allograft inhibits cytokine-induced chemoattractant-1, endothelial leucocyte adhesion molecule, vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression. Clin Exp Immunol (2007) 0.79
Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies. Transplantation (2013) 0.79
Epithelial-mesenchymal transition: potential role in obliterative bronchiolitis? Thorax (2009) 0.79
Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans. Am J Pathol (2015) 0.79
The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease. Transplantation (2013) 0.78
Bone marrow-derived multipotent stromal cells attenuate inflammation in obliterative airway disease in mouse tracheal allografts. Stem Cells Int (2014) 0.77
Clinical and ethical considerations of massively parallel sequencing in transplantation science. World J Transplant (2013) 0.76
De novo-developed antibodies to donor MHC antigens lead to dysregulation of microRNAs and induction of MHC class II. J Immunol (2015) 0.76
Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine. Respir Res (2011) 0.75
Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation. Front Immunol (2016) 0.75
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med (1998) 3.86
Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med (1990) 2.85
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2006) 2.69
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1995) 2.44
Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg (2002) 2.19
The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med (1999) 2.18
A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant (2007) 2.16
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg (1996) 2.15
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. J Heart Lung Transplant (2007) 2.03
Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med (2004) 1.95
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst (1974) 1.60
The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg (1999) 1.59
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report--2006. J Heart Lung Transplant (2006) 1.58
Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol (2004) 1.56
Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation. Am J Transplant (2014) 1.56
Donor lung procurement: assessment and operative technique. Ann Thorac Surg (1993) 1.54
Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation (2007) 1.54
Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54
Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report--2007. J Heart Lung Transplant (2007) 1.51
Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol (2003) 1.50
Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg (1986) 1.47
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg (2000) 1.46
Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg (1991) 1.46
The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation (2005) 1.46
Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg (1998) 1.45
Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger's syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1990) 1.42
Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J Heart Lung Transplant (1997) 1.41
HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41
Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant (2010) 1.41
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40
Preharvest nitroprusside flush improves posttransplantation lung function. J Heart Lung Transplant (1997) 1.40
A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant (2005) 1.39
Strategies to increase limited donor resources. Eur Respir J (2004) 1.38
Separate extraction of cardiac and pulmonary grafts from a single organ donor. Ann Thorac Surg (1988) 1.37
The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant (2002) 1.36
Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg (2010) 1.32
Induction of IL-10 suppressors in lung transplant patients by CD4+25+ regulatory T cells through CTLA-4 signaling. J Immunol (2006) 1.31
Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment. J Infect Dis (2005) 1.31
Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant (2005) 1.31
The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart transplant report--2003. J Heart Lung Transplant (2003) 1.29
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26
Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg (2008) 1.24
Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report--2005. J Heart Lung Transplant (2005) 1.24
Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis (1989) 1.23
Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics (1983) 1.22
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22
Characterization of human IgG Fc receptors. J Immunol (1985) 1.21
Expression of a new cell surface antigen on activated murine macrophages. J Exp Med (1977) 1.21
Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg (2002) 1.21
Smoking cessation and lung cancer resection. Chest (1996) 1.21
Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant (2008) 1.19
Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant (2012) 1.19
Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat (2004) 1.19
Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg (1997) 1.18
CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation. Am J Transplant (2010) 1.17
Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula. Ann Thorac Surg (1981) 1.17
In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers. Hum Immunol (2004) 1.17
Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res (1996) 1.17
Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center. J Thorac Cardiovasc Surg (2010) 1.15
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg (1995) 1.15
The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004. J Heart Lung Transplant (2004) 1.14
Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg (1999) 1.14
Surgeons' concern and practices of protection against bloodborne pathogens. Ann Surg (1998) 1.12
Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res (2003) 1.12
Experiences of women in cardiothoracic surgery. A gender comparison. Arch Surg (1996) 1.11
Cyclosporine in cardiac transplantation. Surg Clin North Am (1985) 1.11
Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant (2004) 1.10
Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1996) 1.10
Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg (1995) 1.10
Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant (2004) 1.09
Redo lung transplantation: a North American-European experience. J Heart Lung Transplant (1993) 1.08
Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1992) 1.08
Monoclonal antibody to human IgG Fc receptors. Cross-linking of receptors induces lysosomal enzyme release and superoxide generation by neutrophils. J Immunol (1988) 1.08
Antigens specific for human lymphocytic and myeloid leukemia cells: detection by nonhuman primate antiserums. Science (1972) 1.08
Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Rev (Orlando) (1987) 1.08
Use of silicone stents in the management of airway problems. Ann Thorac Surg (1989) 1.08
Evaluation of a prototype esophageal detection device. Acad Emerg Med (1995) 1.07
Bronchial dehiscence in lung transplantation: CT evaluation. Radiology (1995) 1.07
Ex vivo adenoviral-mediated gene transfer to lung isografts during cold preservation. Ann Thorac Surg (1997) 1.07
Properties of two monoclonal antibodies directed against the Fc and Fab' regions of rat IgE. Int Arch Allergy Appl Immunol (1983) 1.06
Bronchiolitis obliterans syndrome: pathogenesis and management. Semin Thorac Cardiovasc Surg (2004) 1.05
Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant (2008) 1.05
Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation (1999) 1.04
Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report--2007. J Heart Lung Transplant (2007) 1.04
Induction of obliterative airway disease by anti-HLA class I antibodies. Am J Transplant (2005) 1.03
The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg (1982) 1.02